30.07.2014
- Orion Engineered Carbons has priced its initial public offering (ipo) of 19.5 million common shares on the New York Stock Exchange at $18 per share. The placement was due to close...
16.05.2013
- Sweden's Recipharm has hired UBS to advise on either a partial sale of the pharmaceutical company or a listing on the Stockholm exchange, a source close to the process told Reuters...
